BEAM Asset Management LLC Increases Position in UnitedHealth Group Incorporated (NYSE:UNH)

BEAM Asset Management LLC raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,333 shares of the healthcare conglomerate’s stock after buying an additional 41 shares during the period. BEAM Asset Management LLC’s holdings in UnitedHealth Group were worth $521,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of UNH. Anfield Capital Management LLC purchased a new stake in UnitedHealth Group during the second quarter valued at about $26,000. RPg Family Wealth Advisory LLC purchased a new stake in UnitedHealth Group during the second quarter valued at about $26,000. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. purchased a new stake in UnitedHealth Group during the second quarter valued at about $28,000. Activest Wealth Management purchased a new stake in UnitedHealth Group during the second quarter valued at about $29,000. Finally, Ten Capital Wealth Advisors LLC boosted its position in UnitedHealth Group by 111.6% during the second quarter. Ten Capital Wealth Advisors LLC now owns 91 shares of the healthcare conglomerate’s stock valued at $36,000 after buying an additional 48 shares during the period. Institutional investors and hedge funds own 86.20% of the company’s stock.

Shares of UNH stock opened at $450.16 on Thursday. UnitedHealth Group Incorporated has a 12-month low of $320.35 and a 12-month high of $466.00. The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 0.59. The firm’s 50 day moving average is $430.47 and its 200 day moving average is $418.01. The stock has a market capitalization of $423.98 billion, a P/E ratio of 27.93, a P/E/G ratio of 1.75 and a beta of 0.85.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, October 14th. The healthcare conglomerate reported $4.52 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $4.41 by $0.11. UnitedHealth Group had a net margin of 5.52% and a return on equity of 23.08%. The company had revenue of $72.34 billion for the quarter, compared to analysts’ expectations of $71.24 billion. During the same quarter last year, the company posted $3.51 earnings per share. The firm’s quarterly revenue was up 11.1% on a year-over-year basis. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 18.84 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 14th. Stockholders of record on Monday, December 6th will be paid a dividend of $1.45 per share. This represents a $5.80 annualized dividend and a dividend yield of 1.29%. The ex-dividend date of this dividend is Friday, December 3rd. UnitedHealth Group’s dividend payout ratio is presently 35.98%.

Several equities analysts have recently commented on the stock. Credit Suisse Group upped their price objective on shares of UnitedHealth Group from $462.00 to $495.00 and gave the company an “outperform” rating in a research note on Friday, October 15th. BMO Capital Markets upped their price objective on shares of UnitedHealth Group from $435.00 to $475.00 and gave the company a “market perform” rating in a research note on Monday, October 18th. Cowen initiated coverage on shares of UnitedHealth Group in a research note on Thursday, September 9th. They set an “outperform” rating and a $478.00 price objective for the company. Morgan Stanley increased their price target on shares of UnitedHealth Group from $488.00 to $499.00 and gave the stock an “overweight” rating in a research note on Friday, October 15th. Finally, Deutsche Bank Aktiengesellschaft increased their price target on shares of UnitedHealth Group from $421.00 to $477.00 and gave the stock a “buy” rating in a research note on Tuesday, November 16th. One analyst has rated the stock with a hold rating, twenty-one have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Buy” and an average price target of $477.35.

In other news, Director Stephen J. Hemsley sold 75,000 shares of the firm’s stock in a transaction on Monday, October 25th. The shares were sold at an average price of $448.72, for a total transaction of $33,654,000.00. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Richard T. Burke sold 2,500 shares of UnitedHealth Group stock in a transaction on Tuesday, September 14th. The shares were sold at an average price of $416.75, for a total transaction of $1,041,875.00. Following the completion of the sale, the director now owns 154,403 shares in the company, valued at $64,347,450.25. The disclosure for this sale can be found here. Insiders have sold a total of 82,500 shares of company stock worth $36,855,125 in the last quarter. Corporate insiders own 0.55% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.

Read More: What Is an EV Stock

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.